Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001638599-21-000394
Filing Date
2021-04-01
Accepted
2021-04-01 19:15:12
Documents
2
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3_7183.html 3  
1 PRIMARY DOCUMENT doc3_7183.xml 3 2142
2 EXHIBIT 24 exhibit24.htm EX-24 3333
  Complete submission text file 0001638599-21-000394.txt   6849
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Haller Julia A (Reporting) CIK: 0001656082 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38365 | Film No.: 21800021

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations